VINCERX PHARMA INC's ticker is VINC and the CUSIP is 92731L106. A total of 35 filers reported holding VINCERX PHARMA INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,870 | -22.3% | 25,614 | 0.0% | 0.00% | – |
| Q2 2023 | $33,298 | +25.0% | 25,614 | 0.0% | 0.00% | – |
| Q1 2023 | $26,639 | +2.0% | 25,614 | 0.0% | 0.00% | – |
| Q4 2022 | $26,126 | -25.4% | 25,614 | -0.2% | 0.00% | – |
| Q3 2022 | $35,000 | +2.9% | 25,669 | 0.0% | 0.00% | – |
| Q2 2022 | $34,000 | -93.9% | 25,669 | -81.6% | 0.00% | – |
| Q1 2022 | $560,000 | -61.7% | 139,861 | -2.6% | 0.00% | – |
| Q4 2021 | $1,463,000 | -24.8% | 143,530 | +19.2% | 0.00% | – |
| Q3 2021 | $1,946,000 | +133.3% | 120,363 | +87.7% | 0.00% | – |
| Q2 2021 | $834,000 | +140.3% | 64,141 | +256.8% | 0.00% | – |
| Q1 2021 | $347,000 | – | 17,977 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAGE RHINO CAPITAL LLC | 1,618,199 | $31,231,000 | 10.26% |
| Affinity Asset Advisors, LLC | 543,010 | $10,480,000 | 3.56% |
| ACUTA CAPITAL PARTNERS, LLC | 394,000 | $7,604,000 | 2.74% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $9,650,000 | 2.72% |
| Logos Global Management LP | 480,000 | $9,264,000 | 0.90% |
| Sio Capital Management, LLC | 105,000 | $2,027,000 | 0.41% |
| SABBY MANAGEMENT, LLC | 82,948 | $1,601,000 | 0.31% |
| Monashee Investment Management LLC | 99,999 | $1,930,000 | 0.30% |
| Ikarian Capital, LLC | 438,684 | $8,467,000 | 0.28% |
| RTW INVESTMENTS, LP | 500,000 | $9,650,000 | 0.15% |